VIETNAM CARDIOVASCULAR ULTRASOUND MARKET FORECAST 2026-2034

In November 2024, Vietnam’s National Assembly passed Law No. 51/2024/QH15, amending the Law on Health Insurance, effective July 2025. The reform eliminated administrative boundary restrictions on healthcare registration, expanded covered services, including telehealth and home-based care, and broadened access to cardiac and specialist services without requiring referrals for certain conditions. Together, these policy actions are directly expanding the insured patient base for cardiac diagnostic procedures and reinforcing hospital procurement of cardiovascular ultrasound systems.

Vietnam’s healthcare infrastructure is also expanding rapidly. As of 2024, the country operates 1,645 hospitals, including 384 private facilities, serving over 170 million outpatient visits and 17 million inpatient treatments annually, according to US-ASEAN Business Council data. However, high-quality cardiac imaging remains concentrated in major urban hospitals in Hanoi and Ho Chi Minh City. This creates a significant untapped opportunity.

Government-led healthcare decentralization and growing private hospital investment in secondary cities are gradually broadening access to advanced cardiac imaging, including 3D and 4D echocardiography, beyond the urban centers. For vendors in the cardiovascular imaging market, Vietnam represents a market where near-term volume growth, longer-term infrastructure investment, and favorable policy tailwinds converge into a strong and durable commercial opportunity.

The Vietnam cardiovascular ultrasound market is segmented by device display, technology, application, type, and end-user. The device display segment is further categorized into color display systems and black & white (B/W) display systems.

Color display systems hold the dominant share within the device display segment of the Vietnam cardiovascular ultrasound market. Their position reflects both clinical necessity and the broader direction of cardiac ultrasound technology adoption in the country. Color display systems enable real-time visualization of blood flow, cardiac chamber dynamics, and vascular structures with the color-coded precision that is essential for Doppler-based cardiac assessments.

This capability is central to diagnosing valvular disease, detecting intracardiac shunts, and assessing hemodynamic function, procedures that are performed daily in Vietnam’s hospital cardiology departments and increasingly in its growing network of diagnostic centers. As Vietnam’s hospitals invest in upgrading their imaging fleets, particularly in Hanoi, Ho Chi Minh City, and expanding secondary city centers, color display cardiovascular ultrasound systems are the standard procurement choice. They offer a materially better clinical experience and diagnostic output than older B/W units.

Moreover, the growing adoption of AI-assisted echocardiography tools and automated workflow features is available almost exclusively in color display platforms, further reinforcing their dominance. For vendors operating in the Vietnam cardiovascular imaging market, color display systems represent the highest-volume, highest-value procurement category, and the natural upgrade path as Vietnam’s public and private hospitals modernize their cardiac diagnostic infrastructure over the forecast period.

Some of the top players operating in the Vietnam cardiovascular ultrasound market include GE HealthCare, Koninklijke Philips NV, Siemens Healthineers AG, Canon Medical Systems Corporation, Mindray Medical International Limited, etc.

GE HealthCare is a Chicago, United States-headquartered medical technology company and one of the most established international players in Vietnam’s cardiovascular ultrasound market. Its cardiac ultrasound portfolio spans premium console-based systems to compact point-of-care platforms, all designed to support the full spectrum of echocardiographic procedures across diverse clinical environments. In 2024, GE HealthCare launched the Vscan Air SL, a wireless, pocket-sized dual-probe ultrasound system, and expanded its Venue family of point-of-care ultrasound platforms with AI-assisted cardiac tools.

These compact, AI-enabled platforms are particularly well-suited to Vietnam’s healthcare landscape, where demand is growing for portable cardiac imaging systems that can extend diagnostic reach beyond large urban hospitals into district-level facilities. GE HealthCare’s broad distribution network, established service infrastructure, and longstanding relationships with Vietnam’s public hospital system give it a strong competitive position in the country’s evolving cardiovascular ultrasound market.